Clicky

AbbVie Inc.(ABBV) News

Date Title
Apr 29 RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
Apr 29 United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect
Apr 28 Why AbbVie Stock Trounced the Market Today
Apr 28 S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report
Apr 26 4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
Apr 26 China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz
Apr 26 AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and ...
Apr 26 Q1 2025 AbbVie Inc Earnings Call
Apr 26 How Much Would It Take To Earn $100 A Month From AbbVie Stock
Apr 25 Why AbbVie Stock Topped the Market Today
Apr 25 Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income?
Apr 25 AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs
Apr 25 AbbVie (NYSE:ABBV) Reports US$13 Billion Sales, Submits Application For New Neurotoxin
Apr 25 AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View
Apr 25 Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss
Apr 25 AbbVie Stock Rises on Stronger-Than-Expected Results, Profit Outlook Lift
Apr 25 AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts
Apr 25 Drugmaker Abbvie Ramps Up Domestic Manufacturing Plans on Tariff Threats
Apr 25 AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast
Apr 25 AbbVie Raises Full-Year Outlook as First-Quarter Results Top Street Estimates